Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Pediatric Immunology

Specialized Care and Treatment Strategies for NBS

At a Glance

Children with Nijmegen breakage syndrome need specialist care: infections may require antibody replacement or preventive medicines, while cancer treatment often avoids radiation and uses adjusted chemotherapy. Stem cell transplant is reserved for selected cases and uses reduced-intensity conditioning.

Managing Nijmegen Breakage Syndrome (NBS) requires a highly specialized medical approach. Because your child’s cells are missing the “repair crew” needed to fix DNA breaks, standard medical treatments—especially those for cancer and immune issues—must be carefully modified. The goal of care is to protect the immune system while avoiding treatments that could cause more harm than good [1][2].

Supporting the Immune System

Most children with NBS have some degree of immunodeficiency, meaning their body doesn’t produce enough antibodies to fight off germs [3]. To manage this, doctors often use two main strategies:

  • Immunoglobulin Replacement Therapy: If your child has low antibody levels (IgG) or frequent infections, they may receive regular infusions of immunoglobulins (IVIG or SCIG) [3][4]. This “borrows” antibodies from healthy donors to help your child fight infections. Studies show this can significantly reduce the frequency and severity of respiratory illnesses [3].
  • Antibiotic Prophylaxis: In some cases, especially during intensive treatments, doctors may prescribe a daily low-dose antibiotic or antifungal medicine to prevent infections before they start [1].

A Note on Vaccines: You should discuss all immunizations with your child’s immunologist. Live vaccines depend on a specialist’s assessment of your child’s T-cell function and are often avoided because they can be harmful [5].

Modifying Cancer Treatment

If a child with NBS develops a malignancy like lymphoma, the treatment plan must be radically different from a standard protocol.

  1. Omitting Radiation: Standard radiotherapy (radiation) is generally avoided. Because NBS cells cannot repair the damage radiation causes, it can lead to life-threatening complications or new cancers [1][6].
  2. Customizing Chemotherapy: Standard “full-dose” chemotherapy can be extremely toxic for a child with NBS. Pediatric oncologists individualize the regimen, selecting specific drugs and modifying dosages according to the malignancy, genotype, and expert protocol [1].
  3. Increased Monitoring: Because the risk of complications like severe mouth sores (mucositis), lung issues, and organ toxicity is much higher, children with NBS require intensified supportive care and close monitoring during any treatment [1][2].

The Role of Stem Cell Transplant (HSCT)

A Hematopoietic Stem Cell Transplant (HSCT), also known as a bone marrow transplant, is a complex procedure that can replace the immune system. In NBS, it is not a routine preventive treatment; it does not correct the NBN defect in other tissues (like the brain or other organs), but it may be indicated for specific severe immune or marrow failure, or certain types of cancer [7][8].

  • Reduced-Intensity Conditioning (RIC): A preferred approach for NBS transplants. Standard transplants use high doses of chemotherapy or radiation (myeloablative conditioning) to clear out the old marrow, which is too dangerous for children with NBS [9]. RIC uses lower, less toxic doses of chemotherapy to prepare the body for the new cells [9][10].
  • The Benefits and Risks: While HSCT replaces the immune and blood system, it remains a high-risk procedure that can lead to serious complications like Graft-versus-Host Disease (GVHD) or severe infections [9][11].

Because these decisions are so complex, it is essential that your child is cared for at a center with specific expertise in treating DNA double-strand-break repair disorders [1][12].

Common questions in this guide

When might a child with Nijmegen breakage syndrome need IVIG or SCIG?
Immunoglobulin replacement may be considered when a child has low antibody levels or frequent infections. IVIG is given through a vein and SCIG under the skin; the treating immunologist decides whether it is appropriate and how often it should be given.
Can children with NBS receive live vaccines?
Live vaccines require an individualized review by the child's immunologist, including an assessment of T-cell function. They are often avoided in NBS because they may cause harm when the immune system cannot respond safely, so families should not change the vaccine plan without specialist advice.
Why is radiation usually avoided for children with NBS?
NBS cells have difficulty repairing the DNA damage caused by radiation. Radiotherapy is therefore generally avoided because it can cause life-threatening toxicity or increase the risk of additional cancers.
How is chemotherapy adjusted when a child with NBS develops cancer?
Pediatric oncologists individualize the drugs and doses for the specific cancer, the child's NBN-related defect, and expert treatment protocols. Close monitoring and supportive care are important because mouth sores, lung problems, and organ toxicity can be more severe.
Is a stem cell transplant a routine treatment for NBS?
No. A hematopoietic stem cell transplant is not a routine preventive treatment and may be considered only for selected cases such as severe immune or bone marrow failure or certain cancers; it replaces the immune and blood systems but does not repair the DNA defect in other tissues. It also carries serious risks, including graft-versus-host disease and severe infections.
Why is reduced-intensity conditioning used before HSCT in NBS?
Reduced-intensity conditioning uses lower, less toxic doses of chemotherapy to prepare the body for donor cells. It is preferred over high-dose chemotherapy or radiation because NBS cells are especially vulnerable to treatment-related DNA damage, although transplant risks such as graft-versus-host disease and infection remain.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on our child's current antibody levels and infection history, do they qualify for immunoglobulin replacement therapy (IVIG or SCIG)?
  2. 2.What is the plan for monitoring our child's response to standard vaccines, and should any live vaccines (like MMR or Varicella) be avoided?
  3. 3.If our child requires chemotherapy, how will the drugs and dosages be modified to account for their specific DNA-repair deficiency?
  4. 4.Can you confirm that our child's medical records explicitly state that unnecessary forms of ionizing radiation therapy are contraindicated?
  5. 5.Is our child currently a candidate for a hematopoietic stem cell transplant (HSCT), and what are the specific 'triggers' (like bone marrow failure or frequent infections) that would make us consider it?
  6. 6.If we proceed with a transplant, what specific 'reduced-intensity' conditioning regimen will be used to minimize the risk of severe toxicity?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Clinical course and therapeutic implications for lymphoid malignancies in Nijmegen breakage syndrome.

    Pastorczak A, Szczepanski T, Mlynarski W,

    European journal of medical genetics 2016; (59(3)):126-32.

    PMID: 26826318
  2. 2

    Consensus Recommendations for the Clinical Management of Hematological Malignancies in Patients with DNA Double Stranded Break Disorders.

    Pastorczak A, Attarbaschi A, Bomken S, et al.

    Cancers 2022; (14(8)) doi:10.3390/cancers14082000.

    PMID: 35454905
  3. 3

    Nijmegen breakage syndrome: 25-year experience of diagnosis and treatment in Ukraine.

    Boyarchuk O, Kostyuchenko L, Akopyan H, et al.

    Frontiers in immunology 2024; (15()):1428724 doi:10.3389/fimmu.2024.1428724.

    PMID: 39007137
  4. 4

    Adulthood diagnosis of Nijmegen breakage syndrome in twins with antibody deficiency clinical presentation.

    González MAM, Rodríguez-Sainz C, Cardenas PP, et al.

    Clinical immunology (Orlando, Fla.) 2026; (286()):110732 doi:10.1016/j.clim.2026.110732.

    PMID: 42297123
  5. 5

    Rubella Virus-Associated Cutaneous Granulomatous Disease: a Unique Complication in Immune-Deficient Patients, Not Limited to DNA Repair Disorders.

    Buchbinder D, Hauck F, Albert MH, et al.

    Journal of clinical immunology 2019; (39(1)):81-89 doi:10.1007/s10875-018-0581-0.

    PMID: 30607663
  6. 6

    Generation of NBS1 knockout in Chinese hamster cells revealed ATR role for radiation and etoposide induced DNA damage in absence of NBS1 proteins.

    Badakul G, Maeda J, Kato TA

    Frontiers in oncology 2026; (16()):1776137 doi:10.3389/fonc.2026.1776137.

    PMID: 41959910
  7. 7

    Prospective Study of a Cohort of Russian Nijmegen Breakage Syndrome Patients Demonstrating Predictive Value of Low Kappa-Deleting Recombination Excision Circle (KREC) Numbers and Beneficial Effect of Hematopoietic Stem Cell Transplantation (HSCT).

    Deripapa E, Balashov D, Rodina Y, et al.

    Frontiers in immunology 2017; (8()):807 doi:10.3389/fimmu.2017.00807.

    PMID: 28791007
  8. 8

    Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome.

    Wolska-Kusnierz B, Pastorczak A, Fendler W, et al.

    Clinical cancer research : an official journal of the American Association for Cancer Research 2021; (27(2)):575-584 doi:10.1158/1078-0432.CCR-20-2574.

    PMID: 33082212
  9. 9

    Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders.

    Slack J, Albert MH, Balashov D, et al.

    The Journal of allergy and clinical immunology 2018; (141(1)):322-328.e10 doi:10.1016/j.jaci.2017.02.036.

    PMID: 28392333
  10. 10

    Hematopoietic Stem Cell Transplantation for DNA Double Strand Breakage Repair Disorders.

    Wolska-Kuśnierz B, Gennery AR

    Frontiers in pediatrics 2019; (7()):557 doi:10.3389/fped.2019.00557.

    PMID: 32010653
  11. 11

    Treosulfan-Based Conditioning Regimen in Haematopoietic Stem Cell Transplantation with TCRαβ/CD19 Depletion in Nijmegen Breakage Syndrome.

    Laberko A, Sultanova E, Gutovskaya E, et al.

    Journal of clinical immunology 2020; (40(6)):861-871 doi:10.1007/s10875-020-00811-9.

    PMID: 32602054
  12. 12

    Children with a rare congenital genetic disorder: a systematic review of parent experiences.

    von der Lippe C, Neteland I, Feragen KB

    Orphanet journal of rare diseases 2022; (17(1)):375 doi:10.1186/s13023-022-02525-0.

    PMID: 36253830

This page is for informational purposes only and does not constitute medical advice. It explains specialized NBS care, but your child's immunologist, oncologist, and transplant team must guide decisions about vaccines, chemotherapy, and HSCT.

Get notified when new evidence is published on Nijmegen breakage syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.